Chemotherapy injection during ultrasound for pancreatic cancer
Part of Cancer, Digestive system clinical trials.
This trial tests whether injecting chemotherapy directly into the tumor during an endoscopic ultrasound can help treat pancreatic cancer that has not spread far. It is being added to standard care to try to shrink the tumor and improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with pancreatic cancer (adenocarcinoma) through a biopsy.
- The cancer is locally advanced, meaning it is in the pancreas but has not spread to distant organs.
- You are in reasonably good health (able to care for yourself and be active).
- You have not had previous surgery, chemotherapy, or radiation for this cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether adding focused ultrasound (a treatment that uses sound waves to target the tumor) to standard chemotherapy can help shrink or control pancreatic cancer in people whose cancer is borderline resectable or locally advanced. It aims to see if this combination is more effective than chemotherapy alone.
This trial tests a new injectable treatment (NRT6008) given with standard chemotherapy for people whose pancreatic cancer cannot be removed by surgery. The goal is to see if it helps control the tumor better than chemo alone.
This trial tests a new treatment that uses ultrasound to help chemotherapy reach liver tumors in people with advanced pancreatic cancer. It may help shrink tumors and improve how well the chemotherapy works.
This early-phase trial is testing a new endoscopic (from inside the stomach) approach for pancreatic ductal adenocarcinoma that is locally advanced and cannot be removed with surgery. It may help some people who have already tried first chemotherapy and still have a tumor confined to the pancreas area (no spread).
This study tests a new approach for locally advanced pancreatic cancer that hasn't spread. It combines precise high-dose radiation with an experimental immunotherapy (PCX12) injected directly into the tumor to see if it's safe and tolerable.
This trial tests a procedure that uses sound waves to heat and destroy part of the tumor, combined with an immunotherapy drug called pembrolizumab (Keytruda) that helps your immune system fight the cancer. It is for people with pancreatic cancer that cannot be removed by surgery or has spread to other parts of the body.
Hear when a new Locally Advanced Pancreatic Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.